Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions

Objectives To assess the respective diagnostic value of Sonazoid™ and SonoVue® for characterizing FLLs as benign or malignant and the corresponding safety. Methods This prospective Phase 3 study was conducted at 17 centres in China and Korea (May 2014 to April 2015); 424 patients (20 to 80 years) wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Abdominal imaging 2021-10, Vol.46 (10), p.4647-4659
Hauptverfasser:	Lv, Ke, Zhai, Hongyan, Jiang, Yuxin, Liang, Ping, Xu, Hui-Xiong, Du, Lianfang, Chou, Yi-Hong, Xie, Xiaoyan, Luo, YuKun, Lee, Young Joon, Lee, Jae Young, Hu, Bing, Luo, Baoming, Wang, Yi, Luan, Ying, Kalli, Christina, Chen, Kun, Wang, Wenping, Liang, Ja-Der
Format:	Artikel
Sprache:	eng
Schlagworte:	Confidence intervals Contrast agents Contrast media Diagnostic systems Gastroenterology Hepatobiliary Hepatology Image contrast Image enhancement Imaging Lesions Liver Medical diagnosis Medical imaging Medicine Medicine & Public Health Radiology Safety Statistical analysis Ultrasonic imaging Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objectives To assess the respective diagnostic value of Sonazoid™ and SonoVue® for characterizing FLLs as benign or malignant and the corresponding safety. Methods This prospective Phase 3 study was conducted at 17 centres in China and Korea (May 2014 to April 2015); 424 patients (20 to 80 years) with at least 1 untreated focal liver lesion (FLL) (
ISSN:	2366-004X 2366-0058 2366-0058
DOI:	10.1007/s00261-021-03010-1